Kailera Therapeutics, Inc. (KLRA)
15.85
-0.56
(-3.41%)
USD |
NASDAQ |
Sep 02, 16:00
16.00
+0.15
(+0.95%)
Pre-Market: 08:00
Kailera Therapeutics Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Moderna, Inc. | 2.635B |
| Revolution Medicines, Inc. | 1.287B |
| Sana Biotechnology, Inc. | 129.50M |
| Parabilis Medicines, Inc. | 140.96M |
| Arrowhead Pharmaceuticals, Inc. | 699.56M |